Clinically Isolated Syndrome: Prognostic Markers for Conversion to Multiple Sclerosis and Initiation of Disease-Modifying Therapy

Clinical Neurology - Japan
doi 10.5692/clinicalneurol.51.179
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Societas Neurologica Japonica

Related search

MRI Only Conversion to Multiple Sclerosis Following a Clinically Isolated Syndrome

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2010English

Protein-Based Classifier to Predict Conversion From Clinically Isolated Syndrome to Multiple Sclerosis

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2015English

Multiple Sclerosis Disease-Modifying Therapy and Pregnancy

Multiple Sclerosis
Neurology
2016English

Anxiety and Depressive Symptoms in Clinically Isolated Syndrome and Multiple Sclerosis

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2011English

Childhood Obesity and Risk of Pediatric Multiple Sclerosis and Clinically Isolated Syndrome

Neurology
Neurology
2013English

Biomarkers and Disease Activity in Multiple Sclerosis : A Cohort Study on Patients With Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis

Linköping University Medical Dissertations
2019English

Infections in Patients With Multiple Sclerosis: Implications for Disease-Modifying Therapy

Acta Neurologica Scandinavica
MedicineNeurology
2017English

Multiple Sclerosis Presented as Clinically Isolated Syndrome: The Need for Early Diagnosis and Treatment

Therapeutics and Clinical Risk Management
2008English

Microparticles in Multiple Sclerosis and Clinically Isolated Syndrome: Effect on Endothelial Barrier Function

BMC Neuroscience
NeuroscienceCellularMolecular Neuroscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy